Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

Management tracks: MeiraGTx, Retrophin, Aduro

April 22, 2019 10:34 PM UTC

MeiraGTx Holdings plc (NASDAQ:MGTX) said Katherine Breedis stepped down as CFO on April 16, a little over six months after she joined the gene therapy company. MeiraGTx said COO Richard Giroux will take on the role of CFO.

Retrophin Inc. (NASDAQ:RTRX) said COO Neil McFarlane will depart May 31. The rare disease company did not respond to inquiries regarding plans for a successor.
Aduro Biotech Inc.
(NASDAQ:ADRO) hired Dimitry Nuyten as CMO. He was VP and immuno-oncology clinical development leader at Pfizer Inc. (NYSE:PFE). Nuyten joins three months after Aduro announced it would reduce headcount by 37% and prioritize its pipeline to focus on compounds against STING, via its deals with Novartis AG (NYSE:NVS; SIX:NOVN) and Eli Lilly and Co. (NYSE:LLY), and against TNFSF13...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article